These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 12881083)
61. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial. von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A; BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370 [TBL] [Abstract][Full Text] [Related]
62. Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial. Denguezli W; Trimech A; Haddad A; Hajjaji A; Saidani Z; Faleh R; Sakouhi M Arch Gynecol Obstet; 2007 Aug; 276(2):119-24. PubMed ID: 17219155 [TBL] [Abstract][Full Text] [Related]
63. Medical methods for mid-trimester termination of pregnancy. Wildschut H; Both MI; Medema S; Thomee E; Wildhagen MF; Kapp N Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD005216. PubMed ID: 21249669 [TBL] [Abstract][Full Text] [Related]
64. Induction of labour with intravaginal misoprostol and prostaglandin E2 gel: a comparative study. Nanda S; Singhal SR; Papneja A Trop Doct; 2007 Jan; 37(1):21-4. PubMed ID: 17326881 [TBL] [Abstract][Full Text] [Related]
65. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception. Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563 [TBL] [Abstract][Full Text] [Related]
66. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study]. Verhulsdonk MT; Papatsonis DN; Heydanus R Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323 [TBL] [Abstract][Full Text] [Related]
67. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial. Chawdhary R; Rana A; Pradhan N J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552 [TBL] [Abstract][Full Text] [Related]
68. Vaginal misoprostol 800 microg every 12 h for second-trimester abortion. Carbonell JL; Rodríguez J; Delgado E; Sánchez C; Vargas F; Valera L; Marí J; Valero F; Salvador I; Llorente M Contraception; 2004 Jul; 70(1):55-60. PubMed ID: 15208053 [TBL] [Abstract][Full Text] [Related]
69. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone]. Ebbers S; Creemers JW; Lotgering FK Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731 [TBL] [Abstract][Full Text] [Related]
70. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Tanha FD; Golgachi T; Niroomand N; Ghajarzadeh M; Nasr R Arch Gynecol Obstet; 2013 Jan; 287(1):65-9. PubMed ID: 22903515 [TBL] [Abstract][Full Text] [Related]
72. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Tang OS; Chan CC; Kan AS; Ho PC Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110 [TBL] [Abstract][Full Text] [Related]
73. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial. Oppegaard KS; Qvigstad E; Nesheim BI BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773 [TBL] [Abstract][Full Text] [Related]
74. Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy. Ashok PW; Hamoda H; Nathani F; Flett GM; Templeton A BJOG; 2003 Dec; 110(12):1057-61. PubMed ID: 14664876 [TBL] [Abstract][Full Text] [Related]
76. Effect of vaginal pH on the efficacy of vaginal misoprostol for induction of midtrimester abortion. Abd-El-Maeboud KH; Ghazy AA; Nadeem AA; Al-Sharaky A; Khalil AE J Obstet Gynaecol Res; 2008 Feb; 34(1):78-84. PubMed ID: 18226134 [TBL] [Abstract][Full Text] [Related]
77. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion. Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851 [TBL] [Abstract][Full Text] [Related]
78. Oral versus vaginal misoprostol administered one hour before surgical termination of pregnancy: a randomised controlled trial. Sharma S; Refaey H; Stafford M; Purkayastha S; Parry M; Axby H BJOG; 2005 Apr; 112(4):456-60. PubMed ID: 15777444 [TBL] [Abstract][Full Text] [Related]
79. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy. Su LL; Biswas A; Choolani M; Kalaichelvan V; Singh K Am J Obstet Gynecol; 2005 Oct; 193(4):1410-4. PubMed ID: 16202734 [TBL] [Abstract][Full Text] [Related]
80. Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation. Prasad S; Kumar A; Divya A Fertil Steril; 2009 Jan; 91(1):28-31. PubMed ID: 18295212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]